Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

EpiBiologics, a leader in tissue-selective extracellular protein degradation, today presented the first preclinical data on its EpiTAC bispecific antibody degrader of c-Met, a potential first-in-class ...

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most ...

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of ...

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to cause pain or visible symptoms of illness. Several months from now, or perhaps ...

Stratham's Erin McBride, who survived a brain tumor while pregnant, says she "appreciates every moment" as she prepares to ...

Scientists have implicated the FOXR2 gene in previously unassociated brain tumor types, with implications for diagnosis, prognosis and treatment.

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.